Tenaya Therapeutics, Inc. (TNYA)
0.8404
+0.05
(+6.35%)
USD |
NASDAQ |
May 07, 16:00
0.8255
-0.01
(-1.77%)
After-Hours: 20:00
Tenaya Therapeutics SG&A Expense (TTM) : 24.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.185M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Vericel Corp. | 166.99M |
| Anavex Life Sciences Corp. | 12.80M |
| Protagonist Therapeutics, Inc. | 33.12M |